Selective Activity of Phenylacetate against Malignant Gliomas: Resemblance to Fetal Brain Damage in Phenylketonuria

Cancer Research

Volumn 54, Issue 4, 1994, Pages 891-895

  Samid, Dvorit ^a   Ram, Zvi ^b   Hudgins, W Robert ^a   Shack, Sonsoles ^a   Liu, Lei ^a   Walbridge, Stuart ^b   Oldfield, Edward H ^b   Myers, Charles E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; DNA; MEVALONIC ACID; MONOCLONAL ANTIBODY; PHENYLACETIC ACID; VIMENTIN;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN INJURY; CANCER INHIBITION; CANCER INVASION; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; CYTOSTASIS; DNA SYNTHESIS; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; FEMALE; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; PHENYLKETONURIA; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN SYNTHESIS; RAT;

ANIMALS; BRAIN; BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMANS; MEVALONIC ACID; MICE; MICE, NUDE; PHENYLACETATES; PHENYLKETONURIAS; PROTEIN ISOPRENYLATION; RATS; RATS, INBRED F344; TUMOR CELLS, CULTURED;

EID: 0028210550     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Brandcs. A., Soesan, M., and Fiorentino, M. V. Medical treatment of high grade malignant gliomas in adults: an overview. Anticancer Res., 11: 719-728, 1991.
2. Samid, D., Shack, S., and Sherman, [., T. Phenylacetate: a novel nontoxic inducer of tumor cell differentiation. Cancer Res., 52: 1988-1992, 1992.
3. Loo, Y. H., Scotto, J., and Wisniewski, H. M. Myelin deficiency in experimental phenylketonuria: contribution of the aromatic acid metabolites of phenylalanine. Adv. Exp. “Med. Biol., 100: 453-469, 1978.
4. Wen. G. Y. Wisniewski, H. M. Shek. J. W., Loo, Y. H., and Fulton, T. R. Neuropathology of phenylacetate poisoning in rats: an experimental model of phenylketonuria. Ann. Neurol., 7: 557-566. 1980.
5. Wightman. F. and Light D. L. Identification of phenylacetic acid as a natural auxin in the shoots of higher plants. Phvsiol. Plant 55 17-24, 1981
6. Nuti. M. P., De Bertoldi. M., and Lepidi, A. A. Influence of phenylacetic acid on poly-β-hvdroxvbutvrate polymerization and cell elongation in Asobacter chroococ-atm Beij. Can! J. Microbiol. IS: 1257-1261, 1972.
7. kishorc. G., Sugumaran, M., and Vaidyanathan, C. S. Metabolism of DL-phenylala-nine by Aspergillus mger. J. BacterioL 128: 182-191, 1976.
8. Samid, D., Yell, A., and Prasanna, P. Induction of erythroid differentiation and fetal hemoglobin production in human leukemic cells treated with phenylacetate. Blood, SO: 1576-1581. 1992.
9. Samid. D., Shack, S., and Myers, C. E. Selective growth arrest and maturation of prostate cancer cells in vitro by nontoxic, pharmacological concentrations of phenylacetate. J. Clin. Invest., 91: 2288-2295, 1993.
10. Brusilow. S. W., Danney, M., Waber, L. J., Batshaw, M., Burton, B., Levitsky, L., Roth, K., McKeethren. C., and Ward, J. Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis. N. Engl. J. Med., 310: 1630-1634, 1984.
11. Simell. O., Sipila, I., Rajantie, J., Valle, D. L., and Brusilow, S. W. Waste nitrogen excretion via amino acid acylation: benzoate and phenylacetate in lysinuric protein intolerance. Pediatr. Res., 20: 1117-1121, 1986.
12. Scriver, C. R., and Clow, C. L. Phenylketonuria: epitome of human biochemical genetics. N. Engl. J. Med., 303: 1394-1400, 1980.
13. Lenke, R. R., and Levy, H. L. Maternal phenylketonuria and hyperphenylalaninemia: an international survey of outcome of untreated and treated pregnancies. N. Engl. J. Med., 303: 1202-1208, 1980.
14. Loo, Y. H., Rabe, A., Potempska, A., Wang, P., Fersko, R., and Wisniewski, H. M. Experimental maternal phenylketonuria: an examination of two animal models. Dev. Neurosci., 6: 227-234, 1983.
15. Kandutsch, A. A., and Saucier, S. E. Regulation of sterol synthesis in developing brains of normal and jimpy mice. Arch. Biochem. Biophys., 135: 201-208, 1969.
16. Fumagalli, R., Grossi, E., Paoletti, P., and Paoletti, R. Studies on lipids in brain tumors. I. Occurrence and significance of sterol precursors of cholesterol in human brain tumors. J. Neurochem., 11: 561-565, 1964.
17. Grossi, E., Paoletti, P., and Paoletti, R. An analysis of brain cholesterol and fatty acid biosynthesis. Arch. Int. Physiol. Biochem., 66: 564-572, 1958.
18. Perry, T. L., Hasen, S., Tischler, B., Bunting, R., and Diamond, S. Glutamine depletion in phenylketonuria, a possible cause of the mental defect. N. Engl. J. Med., 282: 761-766, 1970.
19. Weber, G. Biochemical strategy of cancer cells and the design of chemotherapy: G. H. A. Clowes Memorial Lecture. Cancer Res., 43: 3466-3492, 1983.
20. Castillo, M., Zafra, M. F., and Garcia-Peregrin, E. Inhibition of brain and liver 3-hydroxy-3-methylglutaryl-CoA reductase and mevalonate-5-pyrophosphate decarboxylase in experimental hyperphenylalaninemia. Neurochem. Res., 13: 551-555, 1988.
21. Castillo, M., Iglesias, J., Zafra, M. F., and Garcia-Peregrin, E. Inhibition of chick brain cholesterogenic enzymes by phenyl and phenolic derivatives of phenylalanine. Neurochem. Int., 18: 171-174, 1991.
22. Castillo, M., Martinez-Cayuela, M., Zafra, M. F., and Garcia-Peregrin, E. Effect of phenylalanine derivatives on the main regulatory enzymes of hepatic cholestrogen-esis. Mol. Cell. Biochem., 105: 21-25, 1991.
23. Alley, M. C., Scudiero, D. A., Monks, A., Hursey, M. L., Czerwinski, M. J., Fine, D. L., Abbott, B. J., Mayo, J. G., Schoemaker, R. H., and Boyd, M. R. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res., 48: 589-601, 1988.
24. Weizsaecker, M., Deen, D. F., Rosenblum, M. L., Hoshino, T., Gutin, P. H., and Baker, M. The 9L rat brain tumor: description and application of an animal model. J. Neurol., 224: 183-192, 1981.
25. Culver, K. W., Ram, Z., Walbridge, S., Ishii, H., Oldfield, E. H., and Blaese, R. M. In vivo gene transfer with retroviral vector producer cells for treatment of experimental brain tumors. Science (Washington DC), 256: 1550-1552, 1992.
26. Loo, Y. H., Miller, K. L., Nowlin, J., and Horning, M. G. Identification of metabolites of phenylacetic acid in rat brain by plasma desorption mass spectrometry. Life Sci., 26: 657-663, 1990.
27. 14C into cholesterol by human intracranial tumors in vitro. J. Natl. Cancer Inst., 21: 1109-1115, 1958.
28. Rudling, M. J., Angelin, B., Peterson, C. O., and Collins, V. P. Low density lipoprotein receptor activity in human intracranial tumors and its relation to cholesterol requirement. Cancer Res., 50 (suppl.): 483-487, 1990.
29. Goldstein, J. L., and Brown, M. S. Regulation of the mevalonate pathway. Nature (Lond.), 343: 425-430, 1990.
30. Marshall, C. J. Protein prenylation: a mediator of protein-protein interactions. Science (Washington DC), 259: 1865-1866, 1993.
31. Braun, P. E., De Angelis, D., Shtybel, W. W., and Bernier, L. Isoprenoid modification permits 2′,3′-cyclic nucleotide 3′-phosphodiesterase to bind to membranes. J. Neurosci. Res., 30: 540-544, 1991.